Mario Losen

CERTL reduces C16 ceramide, amyloid-β levels, and inflammation in a model of Alzheimer’s disease

Simone M. Crivelli, Qian Luo, Jo Stevens et al. · Alzheimer s Research & Therapy · 2021 · 43 citations · Full text

Reemergence of pathogenic, autoantibody-producing B cell clones in myasthenia gravis following B cell depletion therapy

Miriam L. Fichtner, Kenneth B. Hoehn, Easton E. Ford et al. · Acta Neuropathologica Communications · 2022 · 34 citations · Full text

Immunology, Immune Regulation, Pathology +22

Ceramide analog [18F]F-HPA-12 detects sphingolipid disbalance in the brain of Alzheimer’s disease transgenic mice by functioning as a metabolic probe

Simone M. Crivelli, Daan van Kruining, Qian Luo et al. · Scientific Reports · 2020 · 20 citations · Full text

FTY720 decreases ceramides levels in the brain and prevents memory impairments in a mouse model of familial Alzheimer’s disease expressing APOE4

Simone M. Crivelli, Qian Luo, Daan van Kruining et al. · Biomedicine & Pharmacotherapy · 2022 · 19 citations · Full text

Altered sphingolipid function in Alzheimer's disease; a gene regulatory network approach

Caterina Giovagnoni, Muhammad Ali, Lars Eijssen et al. · Neurobiology of Aging · 2021 · 17 citations · Full text